Detalhe da pesquisa
1.
Prospective assessment of humoral and cellular immune responses to a 3rd COVID-19 mRNA vaccine dose among immunocompromised individuals.
J Infect Dis
; 2023 Nov 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37972260
2.
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients.
Clin Infect Dis
; 77(5): 696-702, 2023 09 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37078720
3.
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS).
Clin Infect Dis
; 75(1): e630-e644, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35179197
4.
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study.
Clin Infect Dis
; 73(3): e815-e821, 2021 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33507235
5.
A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.
J Infect Dis
; 221(10): 1598-1606, 2020 04 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31282542
6.
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy.
Open Forum Infect Dis
; 10(5): ofad278, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-37265667
7.
Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral Therapy.
J Acquir Immune Defic Syndr
; 85(5): 665-669, 2020 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33177477
8.
Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy.
AIDS
; 31(15): 2085-2094, 2017 09 24.
Artigo
Inglês
| MEDLINE | ID: mdl-28723708